ERBB2 and breast carcinoma: The pCR rate differed significantly among the four breast cancer subtypes as follows: HR+HER2- (14.4 %), HR+HER2+ (43.4 %), HR-HER2+ (71.6 %), and TNBC (39.3 %) (p < 0.01).